K100591 is an FDA 510(k) clearance for the SORBACT. Classified as Dressing, Wound, Drug (product code FRO).
Submitted by Abigo Medical AB (Fridley, US). The FDA issued a Cleared decision on January 24, 2011 after a review of 328 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Abigo Medical AB devices